BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blydt-Hansen TD, Gibson IW, Gao A, Dufault B, Ho J. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation. Transplantation. 2015;99:797-804. [PMID: 25222013 DOI: 10.1097/tp.0000000000000419] [Cited by in Crossref: 38] [Cited by in F6Publishing: 16] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Handschin J, Hirt-Minkowski P, Hönger G, Mitrovic S, Savic Prince S, Ho J, Nickerson P, Schaub S. Technical Considerations and Confounders for Urine CXCL10 Chemokine Measurement. Transplant Direct 2020;6:e519. [PMID: 32047847 DOI: 10.1097/TXD.0000000000000959] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
2 Maier M, Takano T, Sapir-Pichhadze R. Changing Paradigms in the Management of Rejection in Kidney Transplantation: Evolving From Protocol-Based Care to the Era of P4 Medicine. Can J Kidney Health Dis 2017;4:2054358116688227. [PMID: 28270929 DOI: 10.1177/2054358116688227] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
3 Lai X, Zheng X, Mathew JM, Gallon L, Leventhal JR, Zhang ZJ. Tackling Chronic Kidney Transplant Rejection: Challenges and Promises. Front Immunol 2021;12:661643. [PMID: 34093552 DOI: 10.3389/fimmu.2021.661643] [Reference Citation Analysis]
4 Dharnidharka VR, Malone A. Biomarkers to detect rejection after kidney transplantation. Pediatr Nephrol 2018;33:1113-22. [PMID: 28631040 DOI: 10.1007/s00467-017-3712-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
5 San Segundo D, Guiral-Foz SA, Benito-Hernández A, Fernández AR, Arnau A, Valero R, Ramos-Barrón MA, García-Unzueta MT, Gómez-Ortega JM, López-Hoyos M, Ruiz JC, Rodrigo E. Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipients. Transpl Immunol 2021;70:101494. [PMID: 34774739 DOI: 10.1016/j.trim.2021.101494] [Reference Citation Analysis]
6 Guzzi F, Cirillo L, Buti E, Becherucci F, Errichiello C, Roperto RM, Hunter JP, Romagnani P. Urinary Biomarkers for Diagnosis and Prediction of Acute Kidney Allograft Rejection: A Systematic Review. Int J Mol Sci 2020;21:E6889. [PMID: 32961825 DOI: 10.3390/ijms21186889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Weseslindtner L, Hedman L, Wang Y, Strassl R, Helanterä I, Aberle SW, Bond G, Hedman K. Longitudinal assessment of the CXCL10 blood and urine concentration in kidney transplant recipients with BK polyomavirus replication-a retrospective study. Transpl Int 2020;33:555-66. [PMID: 31981424 DOI: 10.1111/tri.13584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Leblanc J, Subrt P, Paré M, Hartell D, Sénécal L, Blydt-Hansen T, Cardinal H. Practice Patterns in the Treatment and Monitoring of Acute T Cell-Mediated Kidney Graft Rejection in Canada. Can J Kidney Health Dis 2018;5:2054358117753616. [PMID: 29479453 DOI: 10.1177/2054358117753616] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Christians U, Klawitter J, Klawitter J. Biomarkers in Transplantation--Proteomics and Metabolomics. Ther Drug Monit 2016;38 Suppl 1:S70-4. [PMID: 26418702 DOI: 10.1097/FTD.0000000000000243] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
10 Brunet M, Millán O. Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantation. Expert Rev Clin Pharmacol 2021;:1-13. [PMID: 34607521 DOI: 10.1080/17512433.2021.1987882] [Reference Citation Analysis]
11 Hirt-Minkowski P, De Serres SA, Ho J. Developing renal allograft surveillance strategies - urinary biomarkers of cellular rejection. Can J Kidney Health Dis. 2015;2:28. [PMID: 26285614 DOI: 10.1186/s40697-015-0061-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
12 Ho J, Sharma A, Kroeker K, Carroll R, De Serres S, Gibson IW, Hirt-Minkowski P, Jevnikar A, Kim SJ, Knoll G, Rush DN, Wiebe C, Nickerson P. Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients. BMJ Open 2019;9:e024908. [PMID: 30975673 DOI: 10.1136/bmjopen-2018-024908] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Quintairos L, Colom H, Millán O, Fortuna V, Espinosa C, Guirado L, Budde K, Sommerer C, Lizana A, López-Púa Y, Brunet M. Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients. PLoS One 2021;16:e0245880. [PMID: 33481955 DOI: 10.1371/journal.pone.0245880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ho J, Sharma A, Mandal R, Wishart DS, Wiebe C, Storsley L, Karpinski M, Gibson IW, Nickerson PW, Rush DN. Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10. Transplant Direct 2016;2:e78. [PMID: 27500268 DOI: 10.1097/TXD.0000000000000589] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Arnau A, Benito-Hernández A, Ramos-Barrón MA, García-Unzueta MT, Gómez-Román JJ, Gómez-Ortega JM, López-Hoyos M, San Segundo D, Ruiz JC, Rodrigo E. Urinary C-X-C Motif Chemokine 10 Is Related to Acute Graft Lesions Secondary to T Cell- and Antibody-Mediated Damage. Ann Transplant 2021;26:e929491. [PMID: 33686050 DOI: 10.12659/AOT.929491] [Reference Citation Analysis]
16 Puscz F, Dadras M, Dermietzel A, Jacobsen F, Lehnhardt M, Behr B, Hirsch T, Kueckelhaus M. A chronic rejection model and potential biomarkers for vascularized composite allotransplantation. PLoS One 2020;15:e0235266. [PMID: 32589662 DOI: 10.1371/journal.pone.0235266] [Reference Citation Analysis]
17 Townamchai N, Eiam-Ong S. Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol 2015; 4(5): 487-491 [PMID: 26558185 DOI: 10.5527/wjn.v4.i5.487] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
18 Erpicum P, Hanssen O, Weekers L, Lovinfosse P, Meunier P, Tshibanda L, Krzesinski JM, Hustinx R, Jouret F. Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples. Clin Kidney J 2017;10:106-15. [PMID: 28643819 DOI: 10.1093/ckj/sfw077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
19 Shen J, Guo L, Lei W, Liu S, Yan P, Liu H, Zhou J, Zhou Q, Liu F, Jiang T, Wang H, Wu J, Chen J, Wang R. Urinary donor-derived cell-free DNA as a non-invasive biomarker for BK polyomavirus-associated nephropathy. J Zhejiang Univ Sci B 2021;22:917-28. [PMID: 34783222 DOI: 10.1631/jzus.B2100131] [Reference Citation Analysis]